TSRL is a drug delivery company who provides proprietary technology solutions to enable the oral delivery of therapeutic agents that are challenged by poor solubility, low intestinal permeability and/or high first-pass clearance. Our technology concepts are derived from internal research, oral delivery consulting services to biotech and pharmaceutical companies as well as business development efforts. Once preclinical or clinical proof of concept of the delivery technology has been reached, TSRL is seeking to form strategic partnerships or out-license the technology for further development and commercialization.